Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (7): 440-440.
Previous Articles Next Articles
CHEN Fang, CUI Min*
Received:2018-08-08
Revised:2018-08-08
Online:2018-07-20
Published:2018-08-08
CLC Number:
CHEN Fang, CUI Min*. One Case of Anaphylactic Shock Induced by Dextran Iron Injection[J]. Chinese Journal of Pharmacovigilance, 2018, 15(7): 440-440.
| [1] 旷满华, 熊问婧, 谢新鑫, 等. 不同口服铁剂治疗儿童缺铁性贫血安全性的网络Meta分析[J].中华疾病控制杂志, 2016, 20(10):1047-1052. [2] Reed J, Charytan C, Yee J.The safety of intravenous iron sucrose use in the elderly patient[J]. Consult Pharm, 2007, 22(3):230-238. [3] 苏慧, 周丽莹, 赵桂燕. 右旋糖酐铁肌注致全身过敏及局部坏死5例分析[J]. 中国医院药学杂志, 2008, 28(12):1049-1050. [4] Behera V,Chauhan R, Sinha S, et al.Anaphylactic Shock Secondary to Intravenous Iron Sucrose in Chronic Kidney Disease[J]. Indian J Hematol Blood Transfus, 2015, 31(3):391-393. [5] 程春雷, 范怡云, 祝清芬, 等. 右旋糖酐铁注射液不良反应文献分析[J].中国药业, 2013, 22(8):79-80. [6] Van Wyck D B, Marten M G, Seid M H, et al. Intravenous ferric carboxymaltose compared with oral iron in the treatment of post- partum anemia: a randomized controlled trial[J]. Obstet Gynecol, 2007, 110(2):267-278. [7] 任贻军, 张宏琳. 右旋糖酐铁注射液的少见不良反应[J]. 海峡药学, 2009, 21(8):202-204. [8] Faich G, Strobos J.Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans[J]. Am J Kidney Dis, 1999, 33(3):464-470. [9] Kortenhorst M S, Harmsze A M, Hasaart T H.Anaphylaxis after iron dextran administration in a pregnant woman[J]. Ned Tijdschr Geneeskd, 2012, 156(48):A5264. [10] Wang C, Graham D J, Kane RC, et al.Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products[J]. JAMA, 2015, 314(19):2062-2068. [11] 袁丽, 杨悦. 药品不良反应/事件之“严重(Serious)”与“重度(Severe)”的界定研究[J]. 中国药物警戒, 2016, 14(8):484-488. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
